Tag «ONCOLOGY PORTFOLIO»

MUNDIPHARMA ADDS ELIGARD® TO ONCOLOGY PORTFOLIO WITH THE ACQUISITION OF TOLMAR AUSTRALIA PTY LIMITED

Singapore, 19 February 2018: Mundipharma has today announced the acquisition of specialist pharmaceutical company, Tolmar Australia Pty Limited, (“Tolmar”), including exclusive distribution rights for the oncology medication Eligard® (leuprorelin acetate) in Australia and New Zealand following several months of comprehensive due diligence and negotiation. The acquisition includes the oncology medications Eligard® and Bi-Eligard …

For the Lovers of Fountain Pen & Ink …
Chawm Ganguly

A maverick, jaywalking through life. Communicated in three continents as a journalist and a spin doctor. Print, Television, PR, Photography, Production - has been there, done it all. Author of several books on Corporate Communications, Social Media, Conferencing. Currently focusing on helping Corporates bridge the Traditional-Social Media divide and installing GenX values in Millennial motherboards. For More Visit: www.chawmganguly.com
Fountain Pen Lovers Kolkata
Fountain Pen Lovers Unite!
Corp Comm with Chawm

Corporate Communications is one of the fastest growing specializations in world, as the faculty transforms from being just another marketing tool in the scabbard of the top management, to being the primary driver, in this, the age of information. Information is today sought (and delivered) in an Instant and the efficiency with which the Communication team reacts to such demands often spells the difference between the winners and the also-ran’s, making it one of the most revered power centers of the corporate world. Join me, as I unravel the mysteries. www.chawmganguly.com
SINfully effective PR
X-Linked Lethal
Archives
Archives

➤